RxDoctor Payments Data

Estee Sneed, NP

Family · White Hall, ARNPI 1386035525

Payments from drug & device makers

$379in general payments, 2019–2025

Across 23 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$88
  • Redhill Biopharma Inc.$46
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$30
  • AbbVie$30
  • Amarin Pharma, Inc.$29
  • Corium, LLC$26
  • plus $131 from 9 others

What the payments were for

  • Food & beverage$379100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$379 in reported general payments places this provider in the 50th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$43,590
Medicare patients
213
Services billed
5,111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide49$52,685
OzempicSemaglutide29$27,381
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$19,976
LinzessLinaclotide21$16,642
EliquisApixaban11$8,874
Albuterol Sulfate HfaAlbuterol Sulfate123$2,837
Diclofenac Potassium11$1,822
Gabapentin114$1,471
Doxycycline Hyclate150$1,370
PaxlovidNirmatrelvir/Ritonavir19$1,359
Methylprednisolone155$1,311
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen87$1,212
Omeprazole50$921
Ventolin HfaAlbuterol Sulfate12$836
Potassium Chloride62$790

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$13$52,68549 claims
Novo NordiskOzempic$13$27,38129 claims
GSKTrelegy Ellipta$15$19,97631 claims
AbbVieLinzess$30$16,64221 claims
PfizerEliquis, Paxlovid$13$10,23330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,103 family providers in Arkansas.

Other family in White Hall

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →